levamisole has been researched along with Carcinoma, Transitional Cell in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lamm, DL; Reichert, DF | 1 |
| Akaza, H; Crabtree, WN; Matheny, RB; Soloway, MS | 1 |
| Kato, J; Ohtaguro, K; Tsujimura, S; Ueda, K | 1 |
| Lindner, A; Madgar, I; Many, M; Moroz, C; Twig, S | 1 |
| Baron, B; Dekernion, J; Kaufman, JJ; Skinner, DG; Smith, RB | 1 |
| deKernion, JB; Fahey, JL; Nathanson, SD; Portaro, JK; Zamfirescu, PL | 1 |
| deKernion, J; Kaufman, JJ; Lincoln, B; Skinner, DG; Smith, RB | 1 |
| Lamm, DL; Radwin, HM; Reichert, DF; Yee, GN | 1 |
| Christophersen, IS; Lundbeck, F | 1 |
3 trial(s) available for levamisole and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Levamisole in the treatment of non-invasive and invasive bladder cancer: a preliminary report.
Topics: Aged; Antigens, Neoplasm; Carcinoma, Transitional Cell; Chemotaxis, Leukocyte; Clinical Trials as Topic; Dinitrochlorobenzene; Double-Blind Method; Humans; Leukocyte Count; Levamisole; Monocytes; Placebos; Recurrence; Skin Tests; Urinary Bladder Neoplasms | 1978 |
Acute effects of orally administered levamisole on random monocyte motility and chemotaxis in man.
Topics: Administration, Oral; Adult; Aged; Carcinoma, Transitional Cell; Cell Movement; Chemotaxis, Leukocyte; Clinical Trials as Topic; Female; Humans; Lectins; Levamisole; Lymphocyte Activation; Male; Middle Aged; Monocytes; Urinary Bladder Neoplasms | 1978 |
Preliminary report of the use of levamisole in the treatment of bladder cancer.
Topics: Carcinoma, Transitional Cell; Chemotaxis, Leukocyte; Clinical Trials as Topic; Dinitrochlorobenzene; Double-Blind Method; Female; Humans; Levamisole; Male; Monocytes; Recurrence; Time Factors; Urinary Bladder Neoplasms | 1978 |
6 other study(ies) available for levamisole and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Long term protection in bladder cancer following intralesional immunotherapy.
Topics: Adjuvants, Immunologic; Animals; BCG Vaccine; Carcinoma, Transitional Cell; Cell Line; Evaluation Studies as Topic; Glycolipids; Immunization; Immunotherapy; Levamisole; Mice; Mice, Inbred C3H; Mycobacterium bovis; Neoplasm Recurrence, Local; Time Factors; Urinary Bladder Neoplasms | 1984 |
Chemoimmunotherapy of implanted murine bladder cancer.
Topics: Animals; Carcinoma, Transitional Cell; Drug Therapy, Combination; Female; Levamisole; Mice; Mice, Inbred C3H; Mitomycin; Mitomycins; Neoplasms, Experimental; Organ Size; Spleen; Time Factors; Urinary Bladder Neoplasms | 1983 |
[Treatment of tumors of the urinary bladder with so-called immunopotentiators].
Topics: Adjuvants, Immunologic; Aged; Antibiotics, Antineoplastic; Biological Products; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Female; Humans; Levamisole; Male; Middle Aged; Phytohemagglutinins; Picibanil; Prognosis; Proteoglycans; Skin Tests; Urinary Bladder Neoplasms | 1983 |
Disease-related lymphocyte cytotoxicity in rats bearing transitional cell carcinoma of bladder. Effect of immunomodulators.
Topics: Animals; Carcinoma, Transitional Cell; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Killer Cells, Natural; Levamisole; Lymphocytes; Male; Neoplasms, Experimental; Poly I-C; Rats; T-Lymphocytes; Urinary Bladder Neoplasms | 1982 |
Levamisole immunotherapy of experimental transitional cell carcinoma.
Topics: Animals; Carcinoma, Transitional Cell; Immunotherapy; Levamisole; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Time Factors | 1979 |
Phase II study of adriamycin, 5-fluorouracil, levamisole, and irradiation in carcinoma of the bladder.
Topics: Bone Marrow; Carcinoma, Transitional Cell; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Fluorouracil; Humans; Levamisole; Nausea; Remission, Spontaneous; Urinary Bladder Neoplasms | 1979 |